These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 37554106)
1. Exploring the molecular targets for Type 2 diabetes-induced Alzheimer's disease through bioinformatics analysis. Gao L; Huang C; Li H; Wu S; Zhou X; Ying C Epigenomics; 2023 Jun; 15(11):619-633. PubMed ID: 37554106 [No Abstract] [Full Text] [Related]
2. Exploring Shared Pathogenesis of Alzheimer's Disease and Type 2 Diabetes Mellitus via Co-expression Networks Analysis. Zhu Y; Ding X; She Z; Bai X; Nie Z; Wang F; Wang F; Geng X Curr Alzheimer Res; 2020; 17(6):566-575. PubMed ID: 32781959 [TBL] [Abstract][Full Text] [Related]
3. Identification of the Shared Gene Signatures Between Alzheimer's Disease and Diabetes-Associated Cognitive Dysfunction by Bioinformatics Analysis Combined with Biological Experiment. Chen Y; Ji X; Bao Z J Alzheimers Dis; 2024; 101(2):611-625. PubMed ID: 39213070 [TBL] [Abstract][Full Text] [Related]
4. Linking Diabetes Mellitus with Alzheimer's Disease: Bioinformatics Analysis for the Potential Pathways and Characteristic Genes. Huang C; Luo J; Wen X; Li K Biochem Genet; 2022 Jun; 60(3):1049-1075. PubMed ID: 34779951 [TBL] [Abstract][Full Text] [Related]
5. Shared peripheral blood biomarkers for Alzheimer's disease, major depressive disorder, and type 2 diabetes and cognitive risk factor analysis. Zhang Y; Geng R; Liu M; Deng S; Ding J; Zhong H; Tu Q Heliyon; 2023 Mar; 9(3):e14653. PubMed ID: 36994393 [TBL] [Abstract][Full Text] [Related]
6. The common genes involved in the pathogenesis of Alzheimer's disease and type 2 diabetes and their implication for drug repositioning. Yuan X; Wang H; Zhang F; Zhang M; Wang Q; Wang J Neuropharmacology; 2023 Feb; 223():109327. PubMed ID: 36368623 [TBL] [Abstract][Full Text] [Related]
7. Identification of MEDAG as a Hub Candidate Gene in the Onset and Progression of Type 2 Diabetes Mellitus by Comprehensive Bioinformatics Analysis. Yang J; Yu P Biomed Res Int; 2021; 2021():3947350. PubMed ID: 33728329 [TBL] [Abstract][Full Text] [Related]
8. Common molecular and pathophysiological underpinnings of delirium and Alzheimer's disease: molecular signatures and therapeutic indications. Mosharaf MP; Alam K; Gow J; Mahumud RA; Mollah MNH BMC Geriatr; 2024 Aug; 24(1):716. PubMed ID: 39210294 [TBL] [Abstract][Full Text] [Related]
9. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease. Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676 [TBL] [Abstract][Full Text] [Related]
10. Identification and Experimental Validation of Marker Genes between Diabetes and Alzheimer's Disease. Huang C; Wen X; Xie H; Hu D; Li K Oxid Med Cell Longev; 2022; 2022():8122532. PubMed ID: 35996379 [TBL] [Abstract][Full Text] [Related]
11. Screening Traditional Chinese Medicine Combination for Cotreatment of Alzheimer's Disease and Type 2 Diabetes Mellitus by Network Pharmacology. Wang YZ; Meng L; Zhuang QS; Shen L J Alzheimers Dis; 2021; 80(2):787-797. PubMed ID: 33579846 [TBL] [Abstract][Full Text] [Related]
12. Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer's disease. Huang L; Li Z; Lv Y; Zhang X; Li Y; Li Y; Yu C Sci Rep; 2024 Aug; 14(1):20185. PubMed ID: 39215110 [TBL] [Abstract][Full Text] [Related]
13. Bioinformatic prediction of the molecular links between Alzheimer's disease and diabetes mellitus. Castillo-Velázquez R; Martínez-Morales F; Castañeda-Delgado JE; García-Hernández MH; Herrera-Mayorga V; Paredes-Sánchez FA; Rivera G; Rivas-Santiago B; Lara-Ramírez EE PeerJ; 2023; 11():e14738. PubMed ID: 36778155 [TBL] [Abstract][Full Text] [Related]
14. Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs. Karki R; Kodamullil AT; Hofmann-Apitius M J Alzheimers Dis; 2017; 60(2):721-731. PubMed ID: 28922161 [TBL] [Abstract][Full Text] [Related]
15. Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules. Prashanth G; Vastrad B; Tengli A; Vastrad C; Kotturshetti I BMC Endocr Disord; 2021 Apr; 21(1):80. PubMed ID: 33902539 [TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease and type 2 diabetes mellitus: A systematic review of proteomic studies. Diniz Pereira J; Gomes Fraga V; Morais Santos AL; Carvalho MDG; Caramelli P; Braga Gomes K J Neurochem; 2021 Mar; 156(6):753-776. PubMed ID: 32909269 [TBL] [Abstract][Full Text] [Related]
17. Establishing genomic/transcriptomic links between Alzheimer's disease and type 2 diabetes mellitus by meta-analysis approach. Mirza Z; Kamal MA; Buzenadah AM; Al-Qahtani MH; Karim S CNS Neurol Disord Drug Targets; 2014 Apr; 13(3):501-16. PubMed ID: 24059308 [TBL] [Abstract][Full Text] [Related]
18. Identification of potential markers for type 2 diabetes mellitus via bioinformatics analysis. Lu Y; Li Y; Li G; Lu H Mol Med Rep; 2020 Sep; 22(3):1868-1882. PubMed ID: 32705173 [TBL] [Abstract][Full Text] [Related]
19. Identification and validation of oxidative stress and immune-related hub genes in Alzheimer's disease through bioinformatics analysis. Li S; Xiao J; Huang C; Sun J Sci Rep; 2023 Jan; 13(1):657. PubMed ID: 36635346 [TBL] [Abstract][Full Text] [Related]
20. Identification of Key Regulatory Genes and Pathways in Prefrontal Cortex of Alzheimer's Disease. Yang F; Diao X; Wang F; Wang Q; Sun J; Zhou Y; Xie J Interdiscip Sci; 2020 Mar; 12(1):90-98. PubMed ID: 32006383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]